This list is an analysis based on recent market events. It's not an investment recommendation.
Longbio Pharma (Suzhou) Co., Ltd. operates as a clinical-stage biotechnology company. It focuses on in-house discovery and development of biopharmaceuticals targeting on allergic and autoimmune diseases. The company was founded by Heng Liu and Nai-Chau Sun on October 26, 2020 and is headquartered Suzhou, China.
FAQs
What is LongBio Pharma (Suzhou). stock price today?▼
The current price of 1779.HK is HK$46.52 HKD — it has decreased by -9.49% in the past 24 hours. Watch LongBio Pharma (Suzhou). stock price performance more closely on the chart.
What is LongBio Pharma (Suzhou). stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Hong Kong Exchange exchange LongBio Pharma (Suzhou). stocks are traded under the ticker 1779.HK.
What is LongBio Pharma (Suzhou). market cap?▼
Today LongBio Pharma (Suzhou). has the market capitalization of 3.45B
What is LongBio Pharma (Suzhou). revenue for the last year?▼
LongBio Pharma (Suzhou). revenue for the last year amounts to 0 HKD.
What is LongBio Pharma (Suzhou). net income for the last year?▼
1779.HK net income for the last year is -155.97M HKD.
How many employees does LongBio Pharma (Suzhou). have?▼
As of November 3, 2026, the company has 85 employees.
In which sector is LongBio Pharma (Suzhou). located?▼
LongBio Pharma (Suzhou). operates in the Health & Wellness sector.
When did LongBio Pharma (Suzhou). complete a stock split?▼
LongBio Pharma (Suzhou). has not had any recent stock splits.
Where is LongBio Pharma (Suzhou). headquartered?▼
LongBio Pharma (Suzhou). is headquartered in Changshu, China.